Cross-ancestry discovery of genetic risk variants for lean metabolic dysfunction-associated steatotic liver disease.
Hsu SW, Lin MR, Chou WH et al.
Publication Details
Comprehensive information about this research publication
Abstract
Summary of the research findings
The presence of metabolic dysfunction-associated steatotic liver disease (MASLD) in lean patients challenges the traditional association between fatty liver and obesity. While genome-wide association studies (GWAS) have identified key genetic variants linked to hepatic steatosis, most have focused on Western obese populations and were based on the former non-alcoholic fatty liver disease (NAFLD) criteria. Genetic studies targeting lean MASLD, particularly among the Taiwan Han Chinese population, remain limited. This study addresses this knowledge gap by investigating the genetic architecture of lean MASLD in a Taiwan Han Chinese cohort.
1,720 Taiwan Han Chinese ancestry cases, 5,331 Taiwan Han Chinese ancestry controls
Study Statistics
Key metrics and study information
AI-Generated Summary
AI-generated by DNAGENICSIndependent AI summary of health and genetic findings from the published study
Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.
AI Summary In Progress
Our AI-generated summary of this publication is being prepared. Please check back soon.